The MEST score provides earlier risk prediction in lgA nephropathy.
Barbour SJ, Espino-Hernandez G, Reich HN, Coppo R, Roberts IS, Feehally J, Herzenberg AM, Cattran DC; Oxford Derivation, North American Validation and VALIGA Consortia; Oxford Derivation North American Validation and VALIGA Consortia.
Barbour SJ, et al.
Kidney Int. 2016 Jan;89(1):167-75. doi: 10.1038/ki.2015.322.
Kidney Int. 2016.
PMID: 26759049
Free article.